LVOOX | Value Opportunities Fund Class F3 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Value Opportunities Fund

Summary

Summary

What is the Value Opportunities Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small and mid-sized U.S. companies.

 

Fund Basicsas of 12/31/2021

Total Net Assets
$1.95 B
Inception Date
04/05/2017
Dividend Frequency
Annually
Fund Expense Ratio
0.83%
Number of Holdings
68

Fund Expense Ratio :

0.83%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 27.61% 27.61% 22.06% 12.21% 12.85% -
Lipper Category Avg. Mid-Cap Core Funds 24.59% 24.59% 20.54% 12.26% 12.73% -
Russell 2500™ Index 18.18% 18.18% 21.91% 13.75% 14.15% -

Fund Expense Ratio :

0.83%

Fund Expense Ratio :

0.83%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 27.61% 27.61% 22.06% 12.21% 12.85% -
Lipper Category Avg. Mid-Cap Core Funds 24.59% 24.59% 20.54% 12.26% 12.73% -
Russell 2500™ Index 18.18% 18.18% 21.91% 13.75% 14.15% -

Fund Expense Ratio :

0.83%

TEN LARGEST HOLDINGS as of 12/31/2021View Portfolio

Holding Assets
Carlisle Cos Inc 2.2%
Valvoline Inc 2.2%
BJ's Wholesale Club Holdings Inc 2.1%
Entegris Inc 2.1%
Stewart Information Services Corp 2.1%
Saia Inc 2.0%
Crane Co 1.9%
First Industrial Realty Trust Inc 1.9%
Signature Bank/New York NY 1.9%
STERIS PLC 1.9%

INVESTMENT TEAM

John C. Hardy
John C. Hardy

Portfolio Manager

18 Years of Industry Experience

Supported By 31 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

0.83%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 27.61% 27.61% 22.06% 12.21% 12.85% -
Lipper Category Avg. Mid-Cap Core Funds 24.59% 24.59% 20.54% 12.26% 12.73% -
Russell 2500™ Index 18.18% 18.18% 21.91% 13.75% 14.15% -

Fund Expense Ratio :

0.83%

Fund Expense Ratio :

0.83%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge 27.61% 27.61% 22.06% 12.21% 12.85% -
Lipper Category Avg. Mid-Cap Core Funds 24.59% 24.59% 20.54% 12.26% 12.73% -
Russell 2500™ Index 18.18% 18.18% 21.91% 13.75% 14.15% -

Fund Expense Ratio :

0.83%

Year Fund Returns Russell 2500™ Index
2021 27.61% 18.18%
2020 15.59% 19.99%
2019 23.27% 27.77%
2018 -11.52% -10.00%
2017 10.55% 16.81%
2016 16.85% 17.59%
2015 -2.48% -2.90%
2014 9.59% 7.07%
2013 36.71% 36.80%
2012 10.27% 17.88%
2011 -3.70% -
2010 25.08% -
2009 34.45% -
2008 -27.40% -
2007 11.43% -
2006 - -
Year Q1 Q2 Q3 Q4 Yearly Returns
2021 11.83% 3.75% 1.49% 8.38% 27.61%
2020 -25.31% 21.82% 4.27% 21.84% 15.59%
2019 12.00% 1.70% 1.41% 6.72% 23.27%
2018 -2.53% 2.99% 6.71% -17.40% -11.52%
2017 1.29% 2.11% 2.45% 4.33% 10.55%
2016 3.12% 2.55% 4.40% 5.83% 16.85%
2015 4.21% -0.11% -7.93% 1.75% -2.48%
2014 4.60% 2.90% -5.62% 7.89% 9.59%
2013 14.10% 2.11% 6.76% 9.90% 36.71%
2012 9.12% -7.04% 4.74% 3.79% 10.27%
2011 6.61% -0.32% -20.96% 14.66% -3.70%
2010 9.14% -9.39% 10.67% 14.28% 25.08%
2009 -6.34% 15.22% 19.32% 4.42% 34.45%
2008 -8.47% 0.77% -2.42% -19.33% -27.40%
2007 4.37% 9.43% 0.60% -3.01% 11.43%
2006 - - - 6.76% -

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 09/30/2021

  • The Fund employs a fundamental, bottom-up individual stock selection strategy that focuses on quality companies with compelling valuation over a long term horizon.
  • We initiated a position in shares of CBOE Holdings, Inc., a high-quality, capital-light exchange business in the early stages of an emerging multi-year revenue growth transformation. Over the past few years, CBOE has quietly built a differentiated data and analytics-focused global trading solutions platform that will benefit from new product expansion in both Europe and Asia.
  • We also initiated a position in shares of Brooks Automation, Inc., a company with two high quality businesses, one exposed to semiconductor fab automation and one exposed to fast growing subsegments of the Life Sciences market, namely sample management as well as Cell & Gene therapy. With the semiconductor business in the process of being sold to a private equity firm at a generous price, we believe the Life Sciences business is trading at an attractive normalized free cash yield and at a discount to comparable peers with a significant war chest to invest in organic as well as inorganic growth.  
  • We sold the Fund’s position in Hill-Rom Holdings, an American medical technology provider, after the company was acquired by Baxter, Inc., a medical technology company, in favor of other investment opportunities.
  • We sold the Fund’s position in Dorman Products, Inc., a supplier of automotive replacement parts, in favor of what we consider to be more attractive investment opportunities consistent with our normalized free cash flow methodology.

PORTFOLIO DETAILS as of 12/31/2021

Total Net Assets
$1.95 B
Number of Holdings
68
Weighted Average Market Cap.
10.7 B
P/B Ratio
3.6x
P/E Ratio
20.7x

Contributors & Detractors as of  12/31/2021

Contributors

Holding Contribution
Saia Inc 0.6%
Silicon Motion Technology Corp 0.5%
Stewart Information 0.5%
Carlisle Cos Inc 0.5%
Simpson Manufacturing Co Inc 0.5%

Detractors

Holding Contribution
Caesars Entertainment Inc -0.3%
Turning Pt Brands Inc -0.3%
Alliance Data Systems, Inc. -0.3%
Generac Holdings, Inc. -0.3%
Evercore Partners, Inc. -0.2%

Attribution Analysis 

Value Opportunities Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 01/14/2022
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
11/22/2021 11/23/2021 11/23/2021 $0.05700 $22.98

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/21/2022 11/22/2022 11/22/2022

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $2.5574 $0.3207 $2.8781 $22.98

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/21/2022 11/22/2022

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 12/31/2021

0.83%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2500™ Index is a market cap weighted index that includes the smallest 2,500 companies covered in the Russell 3000 universe of United States-based listed equities.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field